This educational program will serve to provide foundational knowledge regarding the basic clinical concepts of COVID-19 as well as providing a focused discussion on important considerations for experimental pharmacotherapy.
At the completion of this activity, participants will be able to:
- Describe the etiology, pathophysiology and epidemiology of COVID-19
- Identify the signs and symptoms of COVID-19 and risk factors for more severe illness
- Discuss considerations for experimental COVID-19 pharmacotherapy
- David R. Ha, PharmD, BCIDP, Stanford Health Care
Continuing Pharmacy Education
The California Pharmacists Association (#0113) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Upon completing an evaluation form, participants will be awarded 0.75 hours (0.075 CEUs) of Continuing Pharmacy Education Credit. A statement of credit will not be issued. Participants may log onto the CPE monitor website using their individual log in to download their statement of credit. Please allow 4 weeks for processing of CPE credits to the CPE monitor. UAN: 0113-0000-20-103-H04-P; 0113-0000-20-103-H04-T
Activity Type: Knowledge-based
Target Audience: Pharmacists and Technicians in all practice settings
Release Date: 5/1/2020
Expiration Date: 5/1/2023
What to Expect After Registration
After registration, you will receive a confirmation email with instructions on how to participate in the webinar.
***No cancellations or refunds will be issued once user login information has been sent. Unfortunately, due to the online format of this program we are unable to offer exceptions to this policy. It’s recommend that each registrant review the course content prior to submitting payment to ensure the content meets individual educational needs. User has 30 days to complete the on-demand program from registration. If you have questions regarding course content or cancellation policy, please contact CPhA at (916) 779-4518.